BEAT BioTelemetry Stock Forecast Period (n+1y) 22 Dec 2020


Stock Forecast


As of Tue Dec 22 2020 00:00:02 GMT+0000 (Coordinated Universal Time) shares of BEAT BioTelemetry -0.22 percentage change in price since the previous day's close. Around 0 of 34261000 changed hand on the market. The Stock opened at 72.19 with high and low of 71.97 and 72.46 respectively. The price/earnings ratio is: 149.13 and earning per share is 0.48. The stock quoted a 52 week high and low of 27.35 and 73.1 respectively.

BOSTON (AI Forecast Terminal) Tue, Dec 22, '20 AI Forecast today took the forecast actions: In the context of stock price realization of BEAT BioTelemetry is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+1y) for BEAT BioTelemetry as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of BEAT BioTelemetry as below:

BEAT BioTelemetry Credit Rating Overview


We rerate BEAT BioTelemetry because If a breakdown of revenues by business line is not available, we apply a 188% risk weight to the highest annual revenue of the past three years. We use econometric methods for period (n+1y) simulate with Rank Correlation Index (RCI) ANOVA. Reference code is: 4962. Beta DRL value REG 35 Rational Demand Factor LD 5113.747799999999. Our view of a company's financial policy is an important input when assessing its current and future liquidity position. For instance, we assess whether a company has historically had a higher risk appetite and an aggressive acquisition strategy that has strained its liquidity position, or whether it has taken actions to preserve liquidity in past downturns. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for BEAT BioTelemetry as below:
Frequently Asked QuestionsQ: What is BEAT BioTelemetry stock symbol?
A: BEAT BioTelemetry stock referred as NASDAQ:BEAT
Q: What is BEAT BioTelemetry stock price?
A: On share of BEAT BioTelemetry stock can currently be purchased for approximately 72.06
Q: Do analysts recommend investors buy shares of BEAT BioTelemetry ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for BEAT BioTelemetry at daily forecast section
Q: What is the earning per share of BEAT BioTelemetry ?
A: The earning per share of BEAT BioTelemetry is 0.48
Q: What is the market capitalization of BEAT BioTelemetry ?
A: The market capitalization of BEAT BioTelemetry is 2468833164
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com